Viatris Inc

Healthcare · Drug Manufacturers - Specialty & Generic

17.40$ +1.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Viatris Inc (VTRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 3,757 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement VTRS
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	3,057	3,268	2,720	2,962	2,987	3,239	2,685	2,808	2,862	3,079	2,496	2,852	2,962	3,192	2,619	2,731	2,972	3,624	4,430	4,578	4,537	4,342	4,192	4,117	4,078	3,876	3,729	3,919	3,942	3,837	3,663	3,797	3,751	3,528	3,254	3,582	3,760	3,704	3,517	3,757	14,737
Cost of Revenue	1,774	1,933	1,635	1,737	1,809	1,944	1,700	1,846	1,823	2,063	1,690	1,919	1,889	2,104	1,713	1,706	1,814	2,917	3,303	3,250	2,963	2,795	2,421	2,414	2,330	2,602	2,187	2,310	2,251	2,241	2,159	2,351	2,292	2,313	2,093	2,249	2,375	2,569	2,360	2,300	9,604
Gross Profit	1,283	1,335	1,085	1,225	1,178	1,295	984	963	1,039	1,016	805	933	1,072	1,087	906	1,026	1,159	706	1,127	1,328	1,574	1,546	1,771	1,703	1,748	1,274	1,542	1,609	1,691	1,597	1,504	1,445	1,459	1,215	1,161	1,333	1,385	1,135	1,157	1,457	5,133
Research & Development	199	195	218	181	182	202	205	207	144	149	173	148	168	152	114	156	130	155	184	148	152	267	142	163	175	182	183	208	211	203	200	204	198	207	222	219	250	275	249	248	1,022
Selling, General & Administrative	657	709	631	621	665	659	608	623	577	633	608	669	633	654	605	719	658	3,344	3,344	1,205	1,055	1,083	915	981	1,017	1,265	959	1,032	1,054	1,606	1,018	1,358	1,003	1,047	948	929	887	1,031	929	1,135	3,981
Total Operating Expenses	1,414	1,019	857	752	862	874	829	784	701	783	781	837	749	806	721	892	807	1,588	1,394	1,376	1,217	1,350	1,064	1,155	1,188	1,448	1,142	1,239	1,240	2,051	1,300	1,685	1,233	1,395	4,043	1,100	1,133	1,400	1,237	1,450	5,220
Operating Income	-131	316	228	474	317	421	156	179	338	233	24	96	324	281	185	134	351	-881	-266	-48	358	-78	707	549	560	774	400	369	452	-455	204	-240	226	-180	-2,882	233	252	-266	-80	6.3	-87
Interest Expense	144	150	138	136	132	128	132	139	136	135	131	131	129	126	120	116	117	144	169	167	152	148	146	146	153	147	147	144	142	141	138	146	146	120	116	117	120	120	120	121	480
Pre-Tax Income	-325	225	72	325	180	327	11	19	192	77	-115	-52	186	135	31	20	242	-1,014	-441	-219	200	-204	528	389	428	1,469	323	333	402	-855	205	-392	91	-527	-3,097	-217	-7.9	-343	-247	-64	-662
Income Tax Expense	-206	-193	5.2	28	91	83	-77	-19	16	26	-90	116	-4.0	115	9.9	-19	56	-98	596	60	-112	60	128	75	73	458	98	69	71	-89	91	-65	-4.3	-10	-55	-213	120	-2.9	-424	55	-252
Net Income	-120	418	66	297	88	244	87	38	177	51	-25	-169	190	21	21	39	186	-916	-1,038	-279	312	-264	399	314	354	1,011	225	264	332	-766	114	-326	95	-517	-3,042	-4.6	-128	-340	176	-119	-411
EBITDA	265	851	625	882	755	981	641	660	829	821	517	581	784	829	566	552	791	84	1,150	1,265	1,369	218	1,410	1,258	1,280	1,644	1,200	1,163	1,223	-70	1,034	540	906	340	-2,317	578	800	543	644	653	2,641

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings